Rakovina Therapeutics Inc (RKV) — Net Asset Quality Index

Latest as of September 2025: 35.8%

Rakovina Therapeutics Inc (RKV) has a Net Asset Quality Index of 35.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$5.27 Million minus total liabilities of CA$3.38 Million yields net assets of CA$1.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Rakovina Therapeutics Inc assets under control for the complete picture of this company's asset base.

Quality Index

35.8%
Equity / Total Assets

Net Assets

CA$1.89 Million
CAD

Total Assets

CA$5.27 Million
CAD

Total Liabilities

CA$3.38 Million
CAD

Rakovina Therapeutics Inc Net Asset Quality Index Over Time (2021–2024)

This chart shows how Rakovina Therapeutics Inc's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the index stands at 35.8%, representing net assets of CA$1.89 Million against total assets of CA$5.27 Million CAD. See Rakovina Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Rakovina Therapeutics Inc (2021–2024)

The table below presents the year-by-year Net Asset Quality Index for Rakovina Therapeutics Inc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Rakovina Therapeutics Inc worth.

Year Quality Index Net Assets (CAD) Total Assets Total Liabilities Change (pp)
2024 68.9% CA$4.30 Million CA$6.24 Million CA$1.94 Million ▼ -2.2 pp
2023 71.1% CA$3.66 Million CA$5.15 Million CA$1.49 Million ▼ -27.2 pp
2022 98.3% CA$6.01 Million CA$6.12 Million CA$107.05K ▼ -0.4 pp
2021 98.7% CA$8.54 Million CA$8.66 Million CA$113.98K
pp = percentage points